Theraphage is a biotechnology company that designs and develops bacteriophage-based immunotherapeutics that can be used globally for various infectious diseases. The company’s bacteriophage-based vaccines and immuno-oncology systems deliver personalized treatments targetting solid tumor cancers provide;
- Flexible treatment options – Standalone therapies or combinations with existing cancer treatment modalities.
- Safe and targeted therapeutics – Naturally derived anticancer agents that do not pose any intrinsic risk to human health.
- Accessible and cost-effective – The production platform offers an inexpensive, large-scale manufacturing solution.